Published guidance, NICE advice and quality standards | Guidance

Showing 21 to 30 of 118

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable	TA763	2 February 2022	2 February 2022
Daratumumab monotherapy for treating relapsed and refractory multiple myeloma	TA783	13 April 2022	13 April 2022
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)	TA771	9 February 2022	9 February 2022
Diabetes in children and young people	QS125	14 July 2016	31 March 2022
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency	TA779	16 March 2022	16 March 2022
Dupilumab for treating severe asthma with type 2 inflammation	TA751	8 December 2021	8 December 2021
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules	HTG611	23 February 2022	23 February 2022
Elosulfase alfa for treating mucopolysaccharidosis type 4A	HST19	20 April 2022	20 April 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction	TA773	9 March 2022	9 March 2022
Endo-SPONGE for treating low rectal anastomotic leak	HTG605	16 December 2021	16 December 2021